| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | disaccharide binding | 5.53e-05 | 7 | 33 | 2 | GO:0048030 | |
| GeneOntologyMolecularFunction | galactoside binding | 9.47e-05 | 9 | 33 | 2 | GO:0016936 | |
| GeneOntologyMolecularFunction | oligosaccharide binding | 4.94e-04 | 20 | 33 | 2 | GO:0070492 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 1.19e-03 | 127 | 33 | 3 | GO:0016616 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH-OH group of donors | 1.51e-03 | 138 | 33 | 3 | GO:0016614 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 2.62e-03 | 46 | 33 | 2 | GO:0030020 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 3.64e-03 | 188 | 33 | 3 | GO:0005201 | |
| GeneOntologyMolecularFunction | manganese ion binding | 6.13e-03 | 71 | 33 | 2 | GO:0030145 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activator activity | 7.35e-03 | 78 | 33 | 2 | GO:0043539 | |
| GeneOntologyBiologicalProcess | ectodermal placode morphogenesis | 2.06e-06 | 16 | 33 | 3 | GO:0071697 | |
| GeneOntologyBiologicalProcess | ectodermal placode formation | 2.06e-06 | 16 | 33 | 3 | GO:0060788 | |
| GeneOntologyBiologicalProcess | ectodermal placode development | 3.00e-06 | 18 | 33 | 3 | GO:0071696 | |
| GeneOntologyBiologicalProcess | ureteric peristalsis | 7.44e-06 | 3 | 33 | 2 | GO:0072105 | |
| GeneOntologyBiologicalProcess | ureter smooth muscle contraction | 7.44e-06 | 3 | 33 | 2 | GO:0014849 | |
| GeneOntologyBiologicalProcess | mammary placode formation | 1.49e-05 | 4 | 33 | 2 | GO:0060596 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell degranulation | 1.49e-05 | 4 | 33 | 2 | GO:0043322 | |
| GeneOntologyBiologicalProcess | atrioventricular canal morphogenesis | 2.47e-05 | 5 | 33 | 2 | GO:1905222 | |
| GeneOntologyBiologicalProcess | cardiac jelly development | 3.71e-05 | 6 | 33 | 2 | GO:1905072 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell degranulation | 6.91e-05 | 8 | 33 | 2 | GO:0043321 | |
| GeneOntologyBiologicalProcess | mammary gland formation | 8.87e-05 | 9 | 33 | 2 | GO:0060592 | |
| GeneOntologyBiologicalProcess | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules | 1.39e-04 | 63 | 33 | 3 | GO:0007157 | |
| GeneOntologyBiologicalProcess | heart looping | 2.15e-04 | 73 | 33 | 3 | GO:0001947 | |
| GeneOntologyBiologicalProcess | atrioventricular canal development | 2.23e-04 | 14 | 33 | 2 | GO:0036302 | |
| GeneOntologyBiologicalProcess | embryonic digit morphogenesis | 2.24e-04 | 74 | 33 | 3 | GO:0042733 | |
| GeneOntologyBiologicalProcess | urinary tract smooth muscle contraction | 2.57e-04 | 15 | 33 | 2 | GO:0014848 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell activation | 2.57e-04 | 15 | 33 | 2 | GO:0032815 | |
| GeneOntologyBiologicalProcess | peristalsis | 2.57e-04 | 15 | 33 | 2 | GO:0030432 | |
| GeneOntologyBiologicalProcess | negative regulation of CD4-positive, alpha-beta T cell proliferation | 2.57e-04 | 15 | 33 | 2 | GO:2000562 | |
| GeneOntologyBiologicalProcess | determination of heart left/right asymmetry | 2.72e-04 | 79 | 33 | 3 | GO:0061371 | |
| GeneOntologyBiologicalProcess | embryonic heart tube morphogenesis | 2.82e-04 | 80 | 33 | 3 | GO:0003143 | |
| GeneOntologyBiologicalProcess | regulation of oxidoreductase activity | 3.25e-04 | 84 | 33 | 3 | GO:0051341 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte degranulation | 3.33e-04 | 17 | 33 | 2 | GO:0043301 | |
| GeneOntologyBiologicalProcess | muscle cell fate commitment | 3.74e-04 | 18 | 33 | 2 | GO:0042693 | |
| GeneOntologyBiologicalProcess | natural killer cell degranulation | 3.74e-04 | 18 | 33 | 2 | GO:0043320 | |
| GeneOntologyBiologicalProcess | negative regulation of alpha-beta T cell proliferation | 4.17e-04 | 19 | 33 | 2 | GO:0046642 | |
| GeneOntologyBiologicalProcess | positive regulation of defense response to bacterium | 4.17e-04 | 19 | 33 | 2 | GO:1900426 | |
| GeneOntologyBiologicalProcess | regulation of T cell chemotaxis | 4.63e-04 | 20 | 33 | 2 | GO:0010819 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell differentiation | 5.11e-04 | 21 | 33 | 2 | GO:0032823 | |
| GeneOntologyBiologicalProcess | embryonic heart tube development | 5.92e-04 | 103 | 33 | 3 | GO:0035050 | |
| GeneOntologyBiologicalProcess | regulation of defense response to bacterium | 7.88e-04 | 26 | 33 | 2 | GO:1900424 | |
| GeneOntologyBiologicalProcess | regulation of CD4-positive, alpha-beta T cell proliferation | 9.14e-04 | 28 | 33 | 2 | GO:2000561 | |
| GeneOntologyBiologicalProcess | phasic smooth muscle contraction | 1.05e-03 | 30 | 33 | 2 | GO:0014821 | |
| GeneOntologyBiologicalProcess | CD4-positive, alpha-beta T cell proliferation | 1.05e-03 | 30 | 33 | 2 | GO:0035739 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte chemotaxis | 1.12e-03 | 31 | 33 | 2 | GO:1901623 | |
| GeneOntologyBiologicalProcess | positive regulation of regulatory T cell differentiation | 1.12e-03 | 31 | 33 | 2 | GO:0045591 | |
| GeneOntologyBiologicalProcess | inner ear morphogenesis | 1.14e-03 | 129 | 33 | 3 | GO:0042472 | |
| GeneOntologyBiologicalProcess | negative regulation of regulated secretory pathway | 1.19e-03 | 32 | 33 | 2 | GO:1903306 | |
| GeneOntologyBiologicalProcess | endocardial cushion formation | 1.19e-03 | 32 | 33 | 2 | GO:0003272 | |
| GeneOntologyBiologicalProcess | T cell chemotaxis | 1.27e-03 | 33 | 33 | 2 | GO:0010818 | |
| GeneOntologyBiologicalProcess | myoblast differentiation | 1.32e-03 | 136 | 33 | 3 | GO:0045445 | |
| GeneOntologyBiologicalProcess | pharyngeal system development | 1.35e-03 | 34 | 33 | 2 | GO:0060037 | |
| GeneOntologyBiologicalProcess | negative regulation of myoblast differentiation | 1.35e-03 | 34 | 33 | 2 | GO:0045662 | |
| GeneOntologyBiologicalProcess | regulation of T cell differentiation in thymus | 1.60e-03 | 37 | 33 | 2 | GO:0033081 | |
| GeneOntologyBiologicalProcess | natural killer cell differentiation | 1.68e-03 | 38 | 33 | 2 | GO:0001779 | |
| GeneOntologyBiologicalProcess | embryonic limb morphogenesis | 1.69e-03 | 148 | 33 | 3 | GO:0030326 | |
| GeneOntologyBiologicalProcess | embryonic appendage morphogenesis | 1.69e-03 | 148 | 33 | 3 | GO:0035113 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 1.86e-03 | 40 | 33 | 2 | GO:0045953 | |
| GeneOntologyBiologicalProcess | negative regulation of CD4-positive, alpha-beta T cell activation | 1.86e-03 | 40 | 33 | 2 | GO:2000515 | |
| GeneOntologyBiologicalProcess | ear morphogenesis | 1.89e-03 | 154 | 33 | 3 | GO:0042471 | |
| GeneOntologyBiologicalProcess | determination of left/right symmetry | 1.89e-03 | 154 | 33 | 3 | GO:0007368 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell migration | 1.96e-03 | 41 | 33 | 2 | GO:2000406 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 1.96e-03 | 41 | 33 | 2 | GO:0002716 | |
| GeneOntologyBiologicalProcess | natural killer cell activation involved in immune response | 2.05e-03 | 42 | 33 | 2 | GO:0002323 | |
| GeneOntologyBiologicalProcess | positive regulation of macrophage activation | 2.05e-03 | 42 | 33 | 2 | GO:0043032 | |
| GeneOntologyBiologicalProcess | positive regulation of SMAD protein signal transduction | 2.15e-03 | 43 | 33 | 2 | GO:0060391 | |
| GeneOntologyBiologicalProcess | left/right pattern formation | 2.18e-03 | 162 | 33 | 3 | GO:0060972 | |
| GeneOntologyBiologicalProcess | mammary gland development | 2.18e-03 | 162 | 33 | 3 | GO:0030879 | |
| GeneOntologyBiologicalProcess | endocardial cushion morphogenesis | 2.25e-03 | 44 | 33 | 2 | GO:0003203 | |
| GeneOntologyBiologicalProcess | embryonic organ morphogenesis | 2.28e-03 | 351 | 33 | 4 | GO:0048562 | |
| GeneOntologyBiologicalProcess | determination of bilateral symmetry | 2.30e-03 | 165 | 33 | 3 | GO:0009855 | |
| GeneOntologyBiologicalProcess | specification of symmetry | 2.30e-03 | 165 | 33 | 3 | GO:0009799 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | 2.33e-03 | 1186 | 33 | 7 | GO:0007167 | |
| GeneOntologyBiologicalProcess | negative regulation of exocytosis | 2.35e-03 | 45 | 33 | 2 | GO:0045920 | |
| GeneOntologyBiologicalProcess | positive regulation of oxidoreductase activity | 2.46e-03 | 46 | 33 | 2 | GO:0051353 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated cytotoxicity | 2.57e-03 | 47 | 33 | 2 | GO:0001911 | |
| GeneOntologyBiologicalProcess | regulation of T-helper 17 type immune response | 2.57e-03 | 47 | 33 | 2 | GO:2000316 | |
| GeneOntologyBiologicalProcess | positive regulation of interleukin-10 production | 2.67e-03 | 48 | 33 | 2 | GO:0032733 | |
| GeneOntologyBiologicalProcess | hemopoiesis | 2.78e-03 | 1223 | 33 | 7 | GO:0030097 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte migration | 2.79e-03 | 49 | 33 | 2 | GO:2000403 | |
| GeneOntologyBiologicalProcess | regulation of regulatory T cell differentiation | 2.79e-03 | 49 | 33 | 2 | GO:0045589 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | 2.83e-03 | 619 | 33 | 5 | GO:0002009 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte migration | 2.90e-03 | 179 | 33 | 3 | GO:0002687 | |
| GeneOntologyBiologicalProcess | negative regulation of type II interferon production | 3.01e-03 | 51 | 33 | 2 | GO:0032689 | |
| GeneOntologyBiologicalProcess | negative regulation of cell killing | 3.13e-03 | 52 | 33 | 2 | GO:0031342 | |
| GeneOntologyBiologicalProcess | negative regulation of alpha-beta T cell activation | 3.13e-03 | 52 | 33 | 2 | GO:0046636 | |
| GeneOntologyBiologicalProcess | embryonic axis specification | 3.13e-03 | 52 | 33 | 2 | GO:0000578 | |
| GeneOntologyBiologicalProcess | appendage morphogenesis | 3.18e-03 | 185 | 33 | 3 | GO:0035107 | |
| GeneOntologyBiologicalProcess | limb morphogenesis | 3.18e-03 | 185 | 33 | 3 | GO:0035108 | |
| GeneOntologyBiologicalProcess | lymphocyte chemotaxis | 3.25e-03 | 53 | 33 | 2 | GO:0048247 | |
| GeneOntologyBiologicalProcess | regulation of alpha-beta T cell proliferation | 3.25e-03 | 53 | 33 | 2 | GO:0046640 | |
| GeneOntologyBiologicalProcess | regulatory T cell differentiation | 3.37e-03 | 54 | 33 | 2 | GO:0045066 | |
| GeneOntologyBiologicalProcess | regulation of T cell migration | 3.62e-03 | 56 | 33 | 2 | GO:2000404 | |
| Domain | - | 5.53e-07 | 95 | 32 | 5 | 2.60.120.200 | |
| Domain | TBX | 2.84e-06 | 2 | 32 | 2 | IPR022582 | |
| Domain | TBX | 2.84e-06 | 2 | 32 | 2 | PF12598 | |
| Domain | ConA-like_dom | 3.29e-05 | 219 | 32 | 5 | IPR013320 | |
| Domain | Gal-bind_lectin | 2.94e-04 | 15 | 32 | 2 | SM00908 | |
| Domain | GALECTIN | 2.94e-04 | 15 | 32 | 2 | PS51304 | |
| Domain | Galectin_CRD | 2.94e-04 | 15 | 32 | 2 | IPR001079 | |
| Domain | Gal-bind_lectin | 2.94e-04 | 15 | 32 | 2 | PF00337 | |
| Domain | GLECT | 2.94e-04 | 15 | 32 | 2 | SM00276 | |
| Domain | TF_T-box | 3.81e-04 | 17 | 32 | 2 | IPR001699 | |
| Domain | TBOX_3 | 3.81e-04 | 17 | 32 | 2 | PS50252 | |
| Domain | TBOX | 3.81e-04 | 17 | 32 | 2 | SM00425 | |
| Domain | TF_T-box_CS | 3.81e-04 | 17 | 32 | 2 | IPR018186 | |
| Domain | T-box | 3.81e-04 | 17 | 32 | 2 | PF00907 | |
| Domain | - | 3.81e-04 | 17 | 32 | 2 | 2.60.40.820 | |
| Domain | TBOX_1 | 3.81e-04 | 17 | 32 | 2 | PS01283 | |
| Domain | TBOX_2 | 3.81e-04 | 17 | 32 | 2 | PS01264 | |
| Domain | LAM_G_DOMAIN | 1.92e-03 | 38 | 32 | 2 | PS50025 | |
| Domain | Laminin_G_2 | 2.13e-03 | 40 | 32 | 2 | PF02210 | |
| Domain | - | 2.98e-03 | 169 | 32 | 3 | 3.40.50.720 | |
| Domain | NAD(P)-bd_dom | 3.18e-03 | 173 | 32 | 3 | IPR016040 | |
| Domain | p53-like_TF_DNA-bd | 3.71e-03 | 53 | 32 | 2 | IPR008967 | |
| Domain | adh_short | 3.99e-03 | 55 | 32 | 2 | PF00106 | |
| Domain | Laminin_G | 4.43e-03 | 58 | 32 | 2 | IPR001791 | |
| Pubmed | 7.77e-09 | 5 | 33 | 3 | 22002537 | ||
| Pubmed | 6.45e-07 | 175 | 33 | 5 | 28071719 | ||
| Pubmed | Complex functional redundancy of Tbx2 and Tbx3 in mouse limb development. | 8.73e-07 | 2 | 33 | 2 | 35506352 | |
| Pubmed | The T-box transcription factors TBX2 and TBX3 in mammary gland development and breast cancer. | 8.73e-07 | 2 | 33 | 2 | 23624936 | |
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 23388722 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 30223900 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 10468588 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 25394776 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 25371204 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 16990264 | ||
| Pubmed | Galectin-9 Is Critical for Mucosal Adaptive Immunity through the T Helper 17-IgA Axis. | 2.62e-06 | 3 | 33 | 2 | 29458010 | |
| Pubmed | Expression of Drosophila omb-related T-box genes in the developing human and mouse neural retina. | 2.62e-06 | 3 | 33 | 2 | 11726608 | |
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 18005988 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 23585851 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 24477688 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 19776007 | ||
| Pubmed | A unique role for galectin-9 in angiogenesis and inflammatory arthritis. | 2.62e-06 | 3 | 33 | 2 | 29433546 | |
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 26582205 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 37105392 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 9153289 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 33316546 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 18974023 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 9196325 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 9038233 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 23144904 | ||
| Pubmed | Impaired Gal-9 Dysregulates the PBMC-Induced Th1/Th2 Imbalance in Abortion-Prone Matings. | 2.62e-06 | 3 | 33 | 2 | 29651447 | |
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 36479526 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 28704475 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 21146220 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 23242525 | ||
| Pubmed | Galectin-9 in allergic airway inflammation and hyper-responsiveness in mice. | 2.62e-06 | 3 | 33 | 2 | 19851072 | |
| Pubmed | The Role of Galectin-9 as Mediator of Atopic Dermatitis: Effect on Keratinocytes. | 2.62e-06 | 3 | 33 | 2 | 33923930 | |
| Pubmed | Alarmin function of galectin-9 in murine respiratory tularemia. | 2.62e-06 | 3 | 33 | 2 | 25898318 | |
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 31937306 | ||
| Pubmed | Molecular mechanisms of pituitary organogenesis: In search of novel regulatory genes. | 2.62e-06 | 3 | 33 | 2 | 20025935 | |
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 21426359 | ||
| Pubmed | Intracellular Galectin-9 Enhances Proximal TCR Signaling and Potentiates Autoimmune Diseases. | 2.62e-06 | 3 | 33 | 2 | 31969388 | |
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 23836896 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 18282810 | ||
| Pubmed | Holt-Oram syndrome is caused by mutations in TBX5, a member of the Brachyury (T) gene family. | 2.62e-06 | 3 | 33 | 2 | 8988164 | |
| Pubmed | Obesity-induced galectin-9 is a therapeutic target in B-cell acute lymphoblastic leukemia. | 2.62e-06 | 3 | 33 | 2 | 35241678 | |
| Pubmed | Sequence and mapping of galectin-5, a beta-galactoside-binding lectin, found in rat erythrocytes. | 2.62e-06 | 3 | 33 | 2 | 7890611 | |
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 12000749 | ||
| Pubmed | Galectin-9 suppresses Th17 cell development in an IL-2-dependent but Tim-3-independent manner. | 2.62e-06 | 3 | 33 | 2 | 22341088 | |
| Pubmed | Regulation of M1‑type and M2‑type macrophage polarization in RAW264.7 cells by Galectin‑9. | 2.62e-06 | 3 | 33 | 2 | 28990062 | |
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 32380082 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 24083426 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 23667648 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 37279535 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 18579572 | ||
| Pubmed | The protective function of galectin-9 in liver ischemia and reperfusion injury in mice. | 2.62e-06 | 3 | 33 | 2 | 25931247 | |
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 22627368 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 28877989 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 33153471 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 19800850 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 22052881 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 11748239 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 17560833 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 38987795 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 35643073 | ||
| Pubmed | Galectin-9 functionally impairs natural killer cells in humans and mice. | 2.62e-06 | 3 | 33 | 2 | 23408620 | |
| Pubmed | Galectin-9/TIM-3 interaction regulates virus-specific primary and memory CD8 T cell response. | 5.23e-06 | 4 | 33 | 2 | 20463811 | |
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 38686388 | ||
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 22677125 | ||
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 32855403 | ||
| Pubmed | Galectin-3 mediates oligomerization of secreted hensin using its carbohydrate-recognition domain. | 5.23e-06 | 4 | 33 | 2 | 23657851 | |
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 19234217 | ||
| Pubmed | Tbx3 represses E-cadherin expression and enhances melanoma invasiveness. | 5.23e-06 | 4 | 33 | 2 | 18829543 | |
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 18826117 | ||
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 24333756 | ||
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 38853593 | ||
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 35715604 | ||
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 22284968 | ||
| Pubmed | Galectin-9 controls the therapeutic activity of 4-1BB-targeting antibodies. | 5.23e-06 | 4 | 33 | 2 | 24958847 | |
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 19017954 | ||
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 8798150 | ||
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 30120235 | ||
| Pubmed | Galectin-9 Targets NLRP3 for Autophagic Degradation to Limit Inflammation. | 5.23e-06 | 4 | 33 | 2 | 33963043 | |
| Pubmed | Galectin-9: A novel promoter of atherosclerosis progression. | 5.23e-06 | 4 | 33 | 2 | 36459823 | |
| Pubmed | [Expression of Galectin-9 and Tim-3 in lungs of mice with asthma]. | 5.23e-06 | 4 | 33 | 2 | 21575348 | |
| Pubmed | Activation of Tim-3-Galectin-9 pathway improves survival of fully allogeneic skin grafts. | 5.23e-06 | 4 | 33 | 2 | 18346632 | |
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 11839756 | ||
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 33107565 | ||
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 19670381 | ||
| Pubmed | Galectin-9 inhibits TLR7-mediated autoimmunity in murine lupus models. | 5.23e-06 | 4 | 33 | 2 | 29611821 | |
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 30763585 | ||
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 25450716 | ||
| Pubmed | The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. | 5.23e-06 | 4 | 33 | 2 | 16286920 | |
| Pubmed | Galectin-9 regulates the threshold of B cell activation and autoimmunity. | 5.23e-06 | 4 | 33 | 2 | 34369876 | |
| Pubmed | Lgals9 deficiency ameliorates obesity by modulating redox state of PRDX2. | 5.23e-06 | 4 | 33 | 2 | 33727589 | |
| Pubmed | Tim-3-Galectin-9 pathway involves the suppression induced by CD4+CD25+ regulatory T cells. | 5.23e-06 | 4 | 33 | 2 | 19362679 | |
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 33203936 | ||
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 25578313 | ||
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 29844236 | ||
| Pubmed | Influence of galectin-9/Tim-3 interaction on herpes simplex virus-1 latency. | 5.23e-06 | 4 | 33 | 2 | 22021615 | |
| Pubmed | Embryonic implantation in galectin 1/galectin 3 double mutant mice. | 8.72e-06 | 5 | 33 | 2 | 9566950 | |
| Pubmed | 8.72e-06 | 5 | 33 | 2 | 29242193 | ||
| Pubmed | 8.72e-06 | 5 | 33 | 2 | 28951537 | ||
| Pubmed | 8.72e-06 | 5 | 33 | 2 | 26278059 | ||
| Pubmed | 8.72e-06 | 5 | 33 | 2 | 17173667 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr16q23 | 3.18e-03 | 116 | 33 | 2 | chr16q23 | |
| GeneFamily | Galectins | 1.34e-04 | 15 | 21 | 2 | 629 | |
| GeneFamily | T-boxes | 1.94e-04 | 18 | 21 | 2 | 766 | |
| GeneFamily | Collagens | 1.29e-03 | 46 | 21 | 2 | 490 | |
| GeneFamily | Short chain dehydrogenase/reductase superfamily | 3.48e-03 | 76 | 21 | 2 | 743 | |
| Coexpression | GSE42021_TCONV_PLN_VS_CD24LO_TCONV_THYMUS_UP | 4.91e-06 | 200 | 33 | 5 | M9605 | |
| Coexpression | GSE14308_NAIVE_CD4_TCELL_VS_NATURAL_TREG_DN | 1.13e-04 | 200 | 33 | 4 | M3394 | |
| Coexpression | GSE17721_CTRL_VS_GARDIQUIMOD_0.5H_BMDC_UP | 1.13e-04 | 200 | 33 | 4 | M3774 | |
| Coexpression | GSE22601_DOUBLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN | 1.13e-04 | 200 | 33 | 4 | M6249 | |
| Coexpression | GSE20715_0H_VS_6H_OZONE_TLR4_KO_LUNG_UP | 1.13e-04 | 200 | 33 | 4 | M4370 | |
| Coexpression | RUAN_RESPONSE_TO_TNF_DN | 1.35e-04 | 79 | 33 | 3 | M1555 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP | 1.39e-04 | 647 | 33 | 6 | MM981 | |
| Coexpression | RUAN_RESPONSE_TO_TNF_DN | 1.45e-04 | 81 | 33 | 3 | MM1175 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.05e-07 | 194 | 33 | 5 | 735eee6ef25589f935fa922788ebbdbfef61249e | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.12e-07 | 195 | 33 | 5 | f5e91ce20a7ce528dc4c1a968c7bf096bf45c528 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.40e-06 | 157 | 33 | 4 | b9d04ee417c0d8ea0801d10f1c54e138587009fd | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.67e-06 | 182 | 33 | 4 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | Mild-NK|World / Disease group and Cell class | 1.03e-05 | 185 | 33 | 4 | 0565b7c464e1a09e596f5a0b363d2dc9b55c3c50 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.05e-05 | 186 | 33 | 4 | 360c3e9e5c3a943e68e6939b4a47821bfc75b553 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.29e-05 | 196 | 33 | 4 | 1f47916c2663bd88c1e7c19c6a7688f4c7173ad2 | |
| ToppCell | PCW_07-8.5-Mesenchymal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.29e-05 | 196 | 33 | 4 | 8e10802f52e5e1853ea4ad34bf9a32a34e6112b5 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.29e-05 | 196 | 33 | 4 | 1bcae4e0a244af822e2b12b2026a2771316f107d | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.32e-05 | 197 | 33 | 4 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.32e-05 | 197 | 33 | 4 | ea746772adb9df4ddb0508d4ef35f2027bf09c35 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.35e-05 | 198 | 33 | 4 | 447d7182edb2cd8a72ebd3c0d16bc6e4ddcaaa5c | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.37e-05 | 199 | 33 | 4 | ec74ff85d6b61013b1f785b2fca343759feb7843 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.40e-05 | 200 | 33 | 4 | fb53be20392a8309a7393774c774a1b1aec6e676 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Inmt_(Inmt)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 9.76e-05 | 121 | 33 | 3 | 5035e071033cb76a7fc0128716755b14821e8f05 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Inmt_(Inmt)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 9.76e-05 | 121 | 33 | 3 | c96115bd33455296378a257583b49442d00b39ca | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_P2ry12|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.23e-04 | 131 | 33 | 3 | 80630812f8894b9358d36dc2dd03fea7ee870502 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.95e-04 | 153 | 33 | 3 | 1524557514668f515ac1bbe847611f564b265b42 | |
| ToppCell | mild_COVID-19_(asymptomatic)-MAIT|World / disease group, cell group and cell class (v2) | 1.95e-04 | 153 | 33 | 3 | 2b4c69f6db17927d6506a645ac058133e60b0103 | |
| ToppCell | mild_COVID-19_(asymptomatic)-MAIT|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 1.95e-04 | 153 | 33 | 3 | 26852f3d8f80e102e24bcb90e24aac26fdc9a32c | |
| ToppCell | Adult-Immune-B_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.03e-04 | 155 | 33 | 3 | 5857aebd43b901fc9f8c46f2d628582969db9e6a | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-04 | 158 | 33 | 3 | 9f58428f70d1427b20122c5c1cc7bf521d0f4832 | |
| ToppCell | severe_COVID-19-NK_CD56bright|severe_COVID-19 / disease group, cell group and cell class (v2) | 2.15e-04 | 158 | 33 | 3 | c2e8d96fc29aa2388b92b4fd81d2726e1f7a053f | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Pericentral)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-04 | 160 | 33 | 3 | c42bcc6c7d113f0db43febb088b75ca4ac7cb7a3 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.23e-04 | 160 | 33 | 3 | d783d29150033e9181c0e30870070268fed3fd85 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c02-NCAM1|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.31e-04 | 162 | 33 | 3 | 9b1c07f0af657095379380c39d763cab0ad73e74 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.39e-04 | 164 | 33 | 3 | 9e16e52f5a634585f26021bcce9b5d5992ff6db0 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-04 | 168 | 33 | 3 | b98af4043dfa5dfa4413e482879fad88de484675 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-04 | 168 | 33 | 3 | 073b53d4cee6bc8c5c6fce51cf6cd9c316478f69 | |
| ToppCell | -Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 2.61e-04 | 169 | 33 | 3 | 8ebe9a88111c53a09c25a7b6a164a0a17880458d | |
| ToppCell | droplet-Liver-HEPATOCYTES|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-04 | 169 | 33 | 3 | f195467438c589f87224bde7da720dea072d110c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_104|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.61e-04 | 169 | 33 | 3 | 6ff1172da690ca17f7108f1617b255b766971a57 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-04 | 169 | 33 | 3 | 7785cab967a33560830c394c918d6ce625103858 | |
| ToppCell | ileum|World / shred on tissue and cell subclass | 2.66e-04 | 170 | 33 | 3 | 9f1211bd4287620e19a59f21e6ecdca3e42e0260 | |
| ToppCell | Adult-Immune-B_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.71e-04 | 171 | 33 | 3 | 355a246f3395900342d400f6f7c6640cba0d4d5d | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.71e-04 | 171 | 33 | 3 | 317b70d72a4ca5336cfb6a49dc57f8e2a8a1c736 | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-suprabasal_interpapillary|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-04 | 172 | 33 | 3 | 6ece9bb9f31685c918ca4cb7b82cf6ad1cad48af | |
| ToppCell | Control-Stromal-Pericyte|World / Disease state, Lineage and Cell class | 2.75e-04 | 172 | 33 | 3 | 813d4256b05b66ca11b08cc0026459d79f12c0eb | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.80e-04 | 173 | 33 | 3 | 1f16d47f5548e257e4b17f8070c5619780a9c5fd | |
| ToppCell | COVID-19_Moderate-NK_CD56bright|COVID-19_Moderate / disease group, cell group and cell class | 2.80e-04 | 173 | 33 | 3 | a07dcb1e555caaa2235aec219334fcbf2d07f10c | |
| ToppCell | facs-Marrow-Granulocytes-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.80e-04 | 173 | 33 | 3 | a5b6c3d58f7a8e533330798b81496009a31548af | |
| ToppCell | facs-Marrow-Granulocytes-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.80e-04 | 173 | 33 | 3 | cc094992b8027f4cef38f0fb0b76f0d07210d1e2 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-T_cells-gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.85e-04 | 174 | 33 | 3 | ccc79febfcf588d8294ffc712338be96de8a5033 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.85e-04 | 174 | 33 | 3 | 7d2f802f493f19a068e097b2909a9000e2160266 | |
| ToppCell | Control-Stromal-Pericyte|Control / Disease state, Lineage and Cell class | 2.85e-04 | 174 | 33 | 3 | 91fc1f1c891f105a91968c22e2de5321c52b439a | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.90e-04 | 175 | 33 | 3 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.6.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.90e-04 | 175 | 33 | 3 | baaffc9af61f12168d6f7b96eb0b6e98a44a3909 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-04 | 175 | 33 | 3 | 5c38d4b6c03473d841e6203a7efaa6dcb2d59386 | |
| ToppCell | Pericytes-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 2.90e-04 | 175 | 33 | 3 | ddf721023a7afc8085c5de17aa254a6575444c0f | |
| ToppCell | Adult-Immune-B_cell|Adult / Lineage, Cell type, age group and donor | 2.95e-04 | 176 | 33 | 3 | 4aa00dcde907ad83d3aa4bb10439b7b5c4be1e5d | |
| ToppCell | droplet-Pancreas-Exocrine-24m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-04 | 177 | 33 | 3 | a5b54792ef948a1e1de66301a60e051250189f59 | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.99e-04 | 177 | 33 | 3 | 1921226196b2ab7919d9f843e60d9f4bd9ec9c57 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.04e-04 | 178 | 33 | 3 | 8ec2a25dda96c9cc9c2904b6cb18f75a293f4969 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.04e-04 | 178 | 33 | 3 | 6c91331196696e0cf239d105f458e3230659fa38 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell|Adult / Lineage, Cell type, age group and donor | 3.09e-04 | 179 | 33 | 3 | 1fc1f252ca943a2f649d1e627f56acbf15f8e058 | |
| ToppCell | Striatum-Endothelial-MURAL|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.09e-04 | 179 | 33 | 3 | 3d58babf44e47462c3d4129dd2e94a2339fd7ce0 | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.09e-04 | 179 | 33 | 3 | 99167ac678cae5c35b1d4f4a81b32000437c00c2 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.15e-04 | 180 | 33 | 3 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | RA-11._Adipocyte|RA / Chamber and Cluster_Paper | 3.15e-04 | 180 | 33 | 3 | d48a3d27357f7d184132a6805950f93080146b59 | |
| ToppCell | Control-Endothelial_cells-Capillary_endothelial_cells|Control / group, cell type (main and fine annotations) | 3.15e-04 | 180 | 33 | 3 | b043f9ffb9a4cd427a15bebb86a711c7b08866e8 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.15e-04 | 180 | 33 | 3 | 01f2e5d96016823482f89ba503d007d4bd88eeac | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c03-MKI67|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.15e-04 | 180 | 33 | 3 | 1c1b25f1d22518db5469707131510daae84716a3 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.20e-04 | 181 | 33 | 3 | 25915e2500430a902db37d79a749ce2990b69810 | |
| ToppCell | -Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 3.20e-04 | 181 | 33 | 3 | ef579e958f334da0f9415aa7e3d5c02c807954a6 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-04 | 181 | 33 | 3 | 0a44781cc34535f061812d1370f748b7bbdef17b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.20e-04 | 181 | 33 | 3 | 6d1f1ad35778a2a227f966f11f6edd8e89452576 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.20e-04 | 181 | 33 | 3 | d7e04e0ca549eac6d9b1192b6578f9b54943d54f | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_bright-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.20e-04 | 181 | 33 | 3 | 9c4f9abb9335da2b07644bca8faff1baa1bb9f5b | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-04 | 181 | 33 | 3 | 48d28eafbb5f4b141deeb0bf020dfca39e7be7a5 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-innate_lymphocytic-innate_lymphoid_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.25e-04 | 182 | 33 | 3 | b86690c109cdc16844a6cd2216c1bf2bf28efd45 | |
| ToppCell | LA-11._Adipocyte|World / Chamber and Cluster_Paper | 3.30e-04 | 183 | 33 | 3 | b177be283e1553fb1f69a346f1ba79ad00297fa2 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ionocyte|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.30e-04 | 183 | 33 | 3 | ba43bca2b45be1008eebd3f033cecb061fb3a966 | |
| ToppCell | LA-11._Adipocyte|LA / Chamber and Cluster_Paper | 3.30e-04 | 183 | 33 | 3 | 3f9011976782fa8aa95cdd6f00f07a91094d411b | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.30e-04 | 183 | 33 | 3 | 3ef9ac1ae13b6172f9121ab1c129ecaa0fef460f | |
| ToppCell | Pericytes-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 3.35e-04 | 184 | 33 | 3 | cd10d351d91a81dd6dc806cb4e0c8d7861c98e0b | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-luminal_bladder_epithelial_cell_(umbrella_cell)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.35e-04 | 184 | 33 | 3 | 382b1e90b3f437af596750669c0465a169d97095 | |
| ToppCell | critical-Epithelial-Ionocyte|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.35e-04 | 184 | 33 | 3 | 58d36577eff814d46d72f031f3533d71549e3d6e | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.41e-04 | 185 | 33 | 3 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_NK-NK_bright-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.41e-04 | 185 | 33 | 3 | 3b2da51aec057b462749ae39afb8f253afcf38d5 | |
| ToppCell | Control-Endothelial_cells-Endothelial_cells_(other)|Control / group, cell type (main and fine annotations) | 3.46e-04 | 186 | 33 | 3 | c6075fe84226b370c5139066793844ad33ae2db1 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_bright-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.46e-04 | 186 | 33 | 3 | 5ad37549592eab23f166196ebf0cb9c8ddf26082 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.46e-04 | 186 | 33 | 3 | f0b78c7ee20279970ea8961bf59acb5262f2dce5 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.46e-04 | 186 | 33 | 3 | c984e5729958237b101df96d1c89a236faacded6 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.46e-04 | 186 | 33 | 3 | 2b3c814a7dee8286ea113c63dc3de5daf0257d37 | |
| ToppCell | 10x5'-Lung-Lymphocytic_Invariant-Inducer-like-ILC3|Lung / Manually curated celltypes from each tissue | 3.52e-04 | 187 | 33 | 3 | 0e7aa481effdd8c2fbdf8b65852821dec2d92cde | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-bladder_urothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-04 | 187 | 33 | 3 | aa336fb568a24e12c0454265ddd71ed10a6614cf | |
| ToppCell | Adult-Mesenchymal-pericyte_cell|Adult / Lineage, Cell type, age group and donor | 3.52e-04 | 187 | 33 | 3 | 62759efb660179402fb574ce5701c89a2e17bcfe | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.52e-04 | 187 | 33 | 3 | 39756ab418267151d86f9c2553db859f71900bb1 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.52e-04 | 187 | 33 | 3 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 3.52e-04 | 187 | 33 | 3 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | facs-Bladder|facs / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-04 | 187 | 33 | 3 | dd5ca59417fd1b388fd975f0f3e1f3245d66ebc5 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.52e-04 | 187 | 33 | 3 | a9316e2818217ec5feae9cf8816f7249803caee6 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.57e-04 | 188 | 33 | 3 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | RA-11._Adipocyte|World / Chamber and Cluster_Paper | 3.57e-04 | 188 | 33 | 3 | 4dac9d636e5cad4cda540b93d4bfed6b5732c880 | |
| ToppCell | moderate-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.63e-04 | 189 | 33 | 3 | 6011b747e27d61d222380a7bffdd921a68e9b657 | |
| ToppCell | Striatum-Endothelial|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.63e-04 | 189 | 33 | 3 | 95ee3b6d7fbbfcf91c780dfcd0926acec05f0a2d | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 3.63e-04 | 189 | 33 | 3 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | moderate-Lymphoid-NK|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.63e-04 | 189 | 33 | 3 | 22a19365782003c18ec8dddcdbfdaa82c4e330f6 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_bright|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.63e-04 | 189 | 33 | 3 | 3e148accffc6ab249fb0dff7f3bf5a7fff9da773 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_1|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.68e-04 | 190 | 33 | 3 | d24af6af3271e34afab744352afd28be8a7cc5c3 | |
| Computational | Genes in the cancer module 286 | 5.53e-05 | 37 | 22 | 3 | MODULE_286 | |
| Disease | Primary familial dilated cardiomyopathy | 4.27e-04 | 30 | 30 | 2 | cv:C0340427 | |
| Disease | Primary dilated cardiomyopathy | 5.49e-04 | 34 | 30 | 2 | cv:C0007193 | |
| Disease | Familial dilated cardiomyopathy | 9.21e-04 | 44 | 30 | 2 | C0340427 | |
| Disease | folic acid measurement | 1.01e-03 | 46 | 30 | 2 | EFO_0005111 | |
| Disease | Cardiomyopathy | 1.05e-03 | 47 | 30 | 2 | cv:C0878544 | |
| Disease | ocular hypertension, response to triamcinolone acetonide | 1.14e-03 | 49 | 30 | 2 | EFO_0006954, EFO_1001069 | |
| Disease | susceptibility to bacterial meningitis measurement | 1.28e-03 | 52 | 30 | 2 | EFO_0008411 | |
| Disease | mosquito bite reaction size measurement | 1.29e-03 | 212 | 30 | 3 | EFO_0008378 | |
| Disease | basophil count, eosinophil count | 1.86e-03 | 241 | 30 | 3 | EFO_0004842, EFO_0005090 | |
| Disease | cancer (implicated_via_orthology) | 2.51e-03 | 268 | 30 | 3 | DOID:162 (implicated_via_orthology) | |
| Disease | intellectual disability (implicated_via_orthology) | 2.65e-03 | 75 | 30 | 2 | DOID:1059 (implicated_via_orthology) | |
| Disease | thyroxine measurement | 3.23e-03 | 83 | 30 | 2 | EFO_0005130 | |
| Disease | calcium measurement | 3.59e-03 | 628 | 30 | 4 | EFO_0004838 | |
| Disease | Abortion, Tubal | 5.50e-03 | 109 | 30 | 2 | C0000822 | |
| Disease | Early Pregnancy Loss | 5.50e-03 | 109 | 30 | 2 | C3830362 | |
| Disease | Miscarriage | 5.50e-03 | 109 | 30 | 2 | C4552766 | |
| Disease | Spontaneous abortion | 5.50e-03 | 109 | 30 | 2 | C0000786 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TGPEFNRVLFNFGGQ | 376 | Q96M60 | |
| GTLGFPGLNGFQGIE | 321 | Q14031 | |
| FAVGGQYVPGNGFSL | 86 | Q9ULA0 | |
| LPFQGIGTFGNQVGF | 166 | Q9P0M2 | |
| FQPTQTGFLQPGGAL | 236 | Q13227 | |
| GLSEPQFVQFNGGFS | 201 | Q3LIE5 | |
| QGAQGNRYVGFGNTP | 176 | Q8N6T3 | |
| FIQELGFGVAPGFQT | 256 | Q16515 | |
| GFGVAPGFQTFVATQ | 261 | Q16515 | |
| FNFPGNFGGSNAFGP | 721 | Q9NTZ6 | |
| GITFFPVQVNVGGQA | 756 | Q08999 | |
| FSGQFVLGEPQGYGV | 86 | Q5T089 | |
| QGNNSYVFPGVALGV | 451 | P48163 | |
| PFSGTIQGGLQDGFQ | 16 | Q6DKI2 | |
| PFSGTIQGGLQDGFQ | 16 | Q3B8N2 | |
| FIFGVTNFENQPGQG | 126 | Q8IXT1 | |
| GQGPQQVGAGQTFEY | 36 | Q9H0V9 | |
| FGGETQQGVVFVFPG | 416 | P08648 | |
| AFSAQGLVPGGGVQF | 1096 | Q4AC94 | |
| GGIPFILTGEFFQQS | 431 | Q9NRM0 | |
| FGPTGIGFGGLTQQV | 176 | P50461 | |
| LPVRGGNVGINSFGF | 381 | P49327 | |
| GFTVFAGVLNENGPG | 106 | P37059 | |
| GQVGGQVGIFPSNYV | 86 | Q16584 | |
| PLGIVQGFFAQNGVN | 11 | Q9BTE3 | |
| GPLAGDNFVRFVQGG | 446 | Q9UJX0 | |
| GFEGGFNFRTLQPNG | 1256 | Q16363 | |
| SGFFFVAAGQQPGGS | 1776 | Q5T011 | |
| LGFAPGLAGQQFFNG | 501 | O15119 | |
| PVFLNGNSFIQGPSG | 361 | Q9UIU6 | |
| EYGVQGLTGFQGFPG | 1391 | Q17RW2 | |
| QGSADGNGIQGFFYP | 16 | Q8WZ59 | |
| GQQFFGPLGAGQPLF | 476 | Q13207 | |
| PGQGVQSQGKFSFGF | 96 | Q9Y5U5 |